Literature DB >> 26850503

Cardiac manifestations in alcoholic liver disease.

Sandra Milić1, Davorka Lulić2, Davor Štimac1, Alen Ružić2, Luka Zaputović2.   

Abstract

Alcoholic liver disease is the most prevalent cause of progressive liver disease in Europe. Alcoholic cirrhosis occurs in 8%-20% of cases of alcoholic liver disease. It has significant influence on cardiovascular system and haemodynamics through increased heart rate, cardiac output, decreased systemic vascular resistance, arterial pressure and plasma volume expansion. Cirrhotic cardiomyopathy is characterised by systolic and diastolic dysfunction and electrophysiological abnormalities, if no other underlying cardiac disease is present. It is often unmasked only during pharmacological or physiological stress, when compensatory mechanisms of the heart become insufficient to maintain adequate cardiac output. Low-to-moderate intake of alcohol can be cardioprotective. However, heavy drinking is associated with an increased risk of cardiovascular diseases, such as alcoholic cardiomyopathy, arterial hypertension, atrial arrhythmias as well as haemorrhagic and ischaemic stroke. Alcoholic cardiomyopathy is characterised by dilated left ventricle (LV), increased LV mass, normal or reduced LV wall thickness and systolic dysfunction. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Alcoholic cardiomyopathy; Alcoholic liver cirrhosis; Alcoholic liver disease; Cirrhotic cardiomyopathy; Hemodynamics

Mesh:

Year:  2016        PMID: 26850503     DOI: 10.1136/postgradmedj-2015-133755

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  4 in total

Review 1.  Nonalcoholic fatty liver disease and alcoholic liver disease: metabolic diseases with systemic manifestations.

Authors:  Alexander J Kovalic; George Cholankeril; Sanjaya K Satapathy
Journal:  Transl Gastroenterol Hepatol       Date:  2019-09-03

2.  Associations of Fatty Liver Disease with Hypertension, Diabetes, and Dyslipidemia: Comparison between Alcoholic and Nonalcoholic Steatohepatitis.

Authors:  Nobuyuki Toshikuni; Mutsumi Tsuchishima; Atsushi Fukumura; Tomiyasu Arisawa; Mikihiro Tsutsumi
Journal:  Gastroenterol Res Pract       Date:  2017-08-22       Impact factor: 2.260

Review 3.  Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis-Literature Review.

Authors:  Abdulrahman Ismaiel; Dan L Dumitraşcu
Journal:  Front Med (Lausanne)       Date:  2019-09-13

4.  Cardiac dysfunction as an early predictor of portal hypertension in chronic hepatitis C.

Authors:  Cecilia Marconi; Mattia Bellan; Paola Giarda; Rosalba Minisini; Serena Favretto; Michela Emma Burlone; Lisa Franzosi; Mario Pirisi
Journal:  Ann Gastroenterol       Date:  2017-09-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.